- Home
- Johnson & Johnson MedTech
Johnson & Johnson MedTech
-
Contact lenses that darken when exposed to light? Check out the new Acuvue® Oasys with Transitions™ Light Intelligent Technology™
The innovative contact lenses change from clear to dark in less than a minute, helping your eyes adjust to fluctuating light conditions, while also blocking out harmful UV rays. A scientist explains how it all works. -
“I have more than 700 patents": Meet Johnson & Johnson’s most prolific inventor
Frederick Shelton has spent 21 years engineering cutting-edge innovations to help propel medicine forward. On what would have been Thomas Edison’s 172nd birthday, this latter-day great American inventor shares the life-changing medical devices he’s most proud of designing. -
What you need to know about Johnson & Johnson’s 2018 full-year earnings report
Check out this infographic breakdown of the company’s annual earnings report, with key performance highlights from its consumer, pharmaceutical and medical devices businesses over the last year. -
Acuvue Oasys® with Transitions™ Light Intelligent Technology™ contact lenses named one of Time’s Best Inventions of 2018
This first-of-its-kind innovation has a dynamic photochromic filter that responds to changing light conditions. -
“I’m living proof you can survive a brain aneurysm”
For World Stroke Day, Cheryl Dehaut shares how a cutting-edge medical device helped treat a complex aneurysm that had threatened to end her life. -
What you need to know about Johnson & Johnson’s 2018 third-quarter earnings
Learn how the company’s consumer, pharmaceutical and medical devices businesses performed in the third quarter of 2018 in this snapshot of its latest earnings report. -
The future really is bionic: 4 surgical procedures you won’t believe are possible
From a magnetic device that can combat chronic acid reflux to a tiny, tree-like tool that can help treat brain aneurysms, these four amazing innovations are poised to help change the future of medicine. -
Johnson & Johnson’s new Chief Financial Officer answers 7 popular investor questions
Joe Wolk, who has enjoyed a 20-year tenure at Johnson & Johnson, shares his vision for the company’s fiscal future. -
What you need to know about Johnson & Johnson’s 2018 second-quarter earnings
In this recap of Johnson & Johnson’s latest earnings report, you can learn how the company’s consumer, pharmaceutical and medical devices businesses performed in the second quarter of 2018. -
Got dry eye? There’s a new treatment for that
Thirty million Americans suffer from Meibomian gland dysfunction, which causes the majority of dry eye cases. Learn how the LipiFlow® Thermal Pulsation System can help address it—in the blink of an eye.